L, Q., A, A., & SAA, M. (2026). Osteoarthritis: Multitissue pathology, molecular mechanisms, clinical management, and emerging precision and regenerative therapies. Frontiers in pharmacology, 16, 1697192. https://doi.org/10.3389/fphar.2025.1697192
Chicago Style (17th ed.) CitationL, Qiu, Alhaskawi A, and Moqbel SAA. "Osteoarthritis: Multitissue Pathology, Molecular Mechanisms, Clinical Management, and Emerging Precision and Regenerative Therapies." Frontiers in Pharmacology 16 (2026): 1697192. https://doi.org/10.3389/fphar.2025.1697192.
MLA (9th ed.) CitationL, Qiu, et al. "Osteoarthritis: Multitissue Pathology, Molecular Mechanisms, Clinical Management, and Emerging Precision and Regenerative Therapies." Frontiers in Pharmacology, vol. 16, 2026, p. 1697192, https://doi.org/10.3389/fphar.2025.1697192.